Nuclear Medicine Market - Global Industry Size, Share, Trends by Acumen Research and Consulting

Acumen Research and Consulting has announced the addition of the “​Nuclear Medicine Market“ report to their offering.

The Nuclear Medicine Market Industry Report 2018 is an in depth study analyzing the current state of the Nuclear Medicine Market. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Nuclear Medicine Market provides analysis of China market covering the industry trends, recent developments in the market and competitive landscape. Competitive analysis includes competitive information of leading players in China market, their company profiles, product portfolio, capacity, production, and company financials. In addition, report also provides upstream raw material analysis and downstream demand analysis along with the key development trends and sales channel analysis. Research study on Nuclear Medicine Market also discusses the opportunity areas for investors.

Introduction

Nuclear medicines or radiopharmaceuticals together are one of the most common drugs, used for the diagnosis of dysfunction in human body tissues. For both diagnostics and therapeutics reason nuclear medicines are used. Moreover, there are more than 30 specific radio pharmaceuticals used by medical practioners. Different forms of nuclear medicines are used in the treatment of cancer, neurological disorders, gastrointestinal, and other diseases.

Market Dynamics

The increasing prevalence of cancer and cardiac disorder are some of the major factors driving the growth of the market. Moreover, advent of alpha radioimmunotherapy (Rit)-based targeted cancer treatments, improvements in radiotracers, and investment through public and private partnerships to revolutionize diagnostic measures are some of the other factors propelling the growth of the market.

However, short life span of radiopharmaceuticals, high cost of these medicines, and shutting down of several nuclear reactors are some of the restraining factors hampering the growth of the market. Furthermore, upcoming radioisotopes and increasing usage across neurological applications are the opportunities for the growth of the market.

Market Classification and Overview

The global nuclear medicine market is segmented into type, modality, application, procedures, end-user, and region.

On the basis of type, the market is segmented into diagnostics and therapeutics.

Based on the modality, the market is segmented into SPECT, PET, alpha-emitters, beta-emitters, and others.

On the basis of application, the market is segmented into oncology, cardiology, neurology, thyroid, and others.

On the basis of procedures, the market is segmented into cardiovascular, central nervous system, endocrine, skeletal, and others.

On the basis of end-user, the market is segmented into hospitals & diagnostics center and research institutes.

Regional Overview

Geographically, the global nuclear medicine market is bifurcated into four regions such as North America, Europe, Asia Pacific (APAC), and Latin America, Middle East & Africa (LAMEA).

North America is expected to hold the major share during the forecast period 2018-2026 owing to the advancement of novel technologies for radioisotope productions, government funding, and company initiatives in the region.

Asia Pacific is expected to be the largest growing region during the forecasted period owing to the increasing demand for the nuclear medicines, increasing disposable income, and improving healthcare standards.

Europe is expected to dominate the market due to the well developed economic condition, advancement in healthcare infrastructure, and better government initiatives. Additionally, LAMEA is expected to hold the least share ue to lack of knowledge and poor healthcare facilities.

Download Sample Report Copy@ ​https://www.acumenresearchandconsulting.com/request-sample/894

The report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Report Coverage:

Market	Nuclear Medicine Market
Analysis Period	2015 – 2026
Historic Data	2015 – 2016
Base Year	2017
Forecast Data	2018 – 2026
Market Stratification	Type, Modality, Application, Procedures, End-Users, Geography
Regional Scope	North America, Europe, Asia-Pacific, Latin America, Middle East and Africa (MEA)
Report Coverage	Market Trends, Drivers, Restraints, Porter’s Five Forces Analysis, Competitive Analysis,Player Profiling, Value Chain Analysis

View Detail Report@ ​https://www.acumenresearchandconsulting.com/nuclear-medicine-market

Market Players:

The nuclear medicine market comprises of some of the major players such as

• Mallinckrodt plc.
• General Electric Co. (healthcare division),
• Medtronic, Inc.
• Bayer AG
• Cardinal Health, Inc.
• Lantheus Medical Imaging, Inc.
• IBA Group

The Major Market Segments of Global Nuclear Medicine Market are as below:

Market Segmentation

Market By Type

• Diagnostic
• Therapeutic

Market By Modality

• SPECT
• PET
• Alpha-emitters
• Beta-emitters
• Others

Market By Application

• Oncology
• Cardiology
• Neurology
• Thyroid
• Others

Market By Procedures

• Cardiovascular
• Central Nervous System
• Endocrine
• Skeletal
• Others

Market By End-Users

• Hospitals and diagnostic centers
• Research institutes
• Others

Market By Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • Rest of MEA

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope

1.1.1. Definition of Nuclear Medicine

1.1.2. Market Segmentation

1.1.3. List of Abbreviations

1.2. Summary

1.2.1. Market Snapshot

1.2.2. Nuclear Medicine Market By Type

1.2.2.1. Global Nuclear Medicine Market Revenue and Growth Rate Comparison By Type (2015-2026)

1.2.2.2. Global Nuclear Medicine Market Revenue Share By Type in 2017

1.2.2.3. Diagnostic

1.2.2.4. Therapeutic

1.2.2.5. Others

1.2.3. Nuclear Medicine Market By Modality

1.2.3.1. Global Nuclear Medicine Market Revenue and Growth Rate Comparison By Modality (2015-2026)

1.2.3.2. Global Nuclear Medicine Market Revenue Share By Modality in 2017

1.2.3.3. SPECT

1.2.3.4. PET

1.2.3.5. Alpha-emitters

1.2.3.6. Beta-emitters

1.2.3.7. Others

1.2.4. Nuclear Medicine Market By Application

1.2.4.1. Global Nuclear Medicine Market Revenue and Growth Rate Comparison By Application (2015-2026)

1.2.4.2. Global Nuclear Medicine Market Revenue Share By Application in 2017

1.2.4.3. Oncology

1.2.4.4. Cardiology

1.2.4.5. Neurology

1.2.4.6. Thyroid

1.2.4.7. Others

1.2.5. Nuclear Medicine Market By Procedures

1.2.5.1. Global Nuclear Medicine Market Revenue and Growth Rate Comparison By Procedures (2015-2026)

1.2.5.2. Global Nuclear Medicine Market Revenue Share By Procedures in 2017

1.2.5.3. Cardiovascular

1.2.5.4. Central Nervous System

1.2.5.5. Endocrine

1.2.5.6. Skeletal

1.2.5.7. Others

1.2.6. Nuclear Medicine Market By End-Users

1.2.6.1. Global Nuclear Medicine Market Revenue and Growth Rate Comparison By End-Users (2015-2026)

1.2.6.2. Global Nuclear Medicine Market Revenue Share By End-Users in 2017

1.2.6.3. Hospitals and diagnostic centers

1.2.6.4. Research institutes

1.2.6.5. Others

1.2.7. Nuclear Medicine Market by Geography

1.2.7.1. Global Nuclear Medicine Market Revenue and Growth Rate Comparison by Geography (2015-2026)

1.2.7.2. North America Nuclear Medicine Market Revenue and Growth Rate (2015-2026)

1.2.7.3. Europe Nuclear Medicine Market Revenue and Growth Rate (2015-2026)

1.2.7.4. Asia-Pacific Nuclear Medicine Market Revenue and Growth Rate (2015-2026)

1.2.7.5. Latin America Nuclear Medicine Market Revenue and Growth Rate (2015-2026)

1.2.7.6. Middle East and Africa (MEA) Nuclear Medicine Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers

2.2. Restraints and Challenges

2.3. Growth Opportunities

2.4. Porter’s Five Forces Analysis

2.4.1. Bargaining Power of Suppliers

2.4.2. Bargaining Power of Buyers

2.4.3. Threat of Substitute

2.4.4. Threat of New Entrants

2.4.5. Degree of Competition

2.5. Value Chain Analysis

2.6. Cost Structure Analysis

2.6.1. Raw Material and Suppliers

2.6.2. Manufacturing Process Analysis

2.7. Regulatory Compliance

2.8. Competitive Landscape, 2017

2.8.1. Player Positioning Analysis

2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Nuclear Medicine Major Manufacturers in 2017

3.2. Manufacturing Plants Distribution of Global Nuclear Medicine Major Manufacturers in 2017

3.3. R&D Status and Technology Source of Global Nuclear Medicine Major Manufacturers in 2017

3.4. Raw Materials Sources Analysis of Global Nuclear Medicine Major Manufacturers in 2017

CHAPTER 4. Nuclear Medicine MARKET BY TYPE

4.1. Global Nuclear Medicine Revenue By Type

4.2. Diagnostic

4.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)

4.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

4.3. Therapeutic

4.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)

4.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

4.4. Others

4.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)

4.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

CHAPTER 5. Nuclear Medicine MARKET By Modality

5.1. Global Nuclear Medicine Revenue By Modality

5.2. SPECT

5.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)

5.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

5.3. PET

5.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)

5.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

5.4. Alpha-emitters

5.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)

5.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

5.5. Beta-emitters

5.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)

5.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

5.6. Others

5.6.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)

5.6.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

CHAPTER 6. Nuclear Medicine MARKET By Application

6.1. Global Nuclear Medicine Revenue By Application

6.2. Oncology

6.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)

6.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

6.3. Cardiology

6.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)

6.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

6.4. Neurology

6.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)

6.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

6.5. Thyroid

6.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)

6.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

6.6. Others

6.6.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)

6.6.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

CHAPTER 7. Nuclear Medicine MARKET By Procedures

7.1. Global Nuclear Medicine Revenue By Procedures

7.2. Cardiovascular

7.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)

7.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

7.3. Central Nervous System

7.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)

7.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

7.4. Endocrine

7.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)

7.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

7.5. Skeletal

7.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)

7.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

7.6. Others

7.6.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)

7.6.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

CHAPTER 8. Nuclear Medicine MARKET By End-Users

8.1. Global Nuclear Medicine Revenue By End-Users

8.2. Hospitals and diagnostic centers

8.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)

8.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

8.3. Research institutes

8.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)

8.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

8.4. Others

8.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)

8.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

CHAPTER 9. NORTH AMERICA Nuclear Medicine MARKET BY COUNTRY

9.1. North America Nuclear Medicine Market Revenue and Growth Rate, 2015 – 2026 ($Million)

9.2. North America Nuclear Medicine Market Revenue Share Comparison, 2015 & 2026 (%)

9.3. U.S.

9.3.1. U.S. Nuclear Medicine Market Revenue and Forecast By Type, 2015 – 2026 ($Million)

9.3.2. Market Revenue and Forecast By Modality, 2015 – 2026 ($Million)

9.4. Canada

9.4.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)

9.4.2. Market Revenue and Forecast By Modality, 2015 – 2026 ($Million)

9.5. Mexico

9.5.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)

9.5.2. Market Revenue and Forecast By Modality, 2015 – 2026 ($Million)

CHAPTER 10. EUROPE Nuclear Medicine MARKET BY COUNTRY

10.1. Europe Nuclear Medicine Market Revenue and Growth Rate, 2015 – 2026 ($Million)

10.2. Europe Nuclear Medicine Market Revenue Share Comparison, 2015 & 2026 (%)

10.3. UK

10.3.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)

10.3.2. Market Revenue and Forecast By Modality, 2015 – 2026 ($Million)

10.4. Germany

10.4.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)

10.4.2. Market Revenue and Forecast By Modality, 2015 – 2026 ($Million)

10.5. France

10.5.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)

10.5.2. Market Revenue and Forecast By Modality, 2015 – 2026 ($Million)

10.6. Spain

10.6.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)

10.6.2. Market Revenue and Forecast By Modality, 2015 – 2026 ($Million)

10.7. Rest of Europe

10.7.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)

10.7.2. Market Revenue and Forecast By Modality, 2015 – 2026 ($Million)

CHAPTER 11. ASIA-PACIFIC Nuclear Medicine MARKET BY COUNTRY

11.1. Asia-Pacific Nuclear Medicine Market Revenue and Growth Rate, 2015 – 2026 ($Million)

11.2. Asia-Pacific Nuclear Medicine Market Revenue Share Comparison, 2015 & 2026 (%)

11.3. China

11.3.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)

11.3.2. Market Revenue and Forecast By Modality, 2015 – 2026 ($Million)

11.4. Japan

11.4.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)

11.4.2. Market Revenue and Forecast By Modality, 2015 – 2026 ($Million)

11.5. India

11.5.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)

11.5.2. Market Revenue and Forecast By Modality, 2015 – 2026 ($Million)

11.6. Australia

11.6.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)

11.6.2. Market Revenue and Forecast By Modality, 2015 – 2026 ($Million)

11.7. South Korea

11.7.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)

11.7.2. Market Revenue and Forecast By Modality, 2015 – 2026 ($Million)

11.8. Rest of Asia-Pacific

11.8.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)

11.8.2. Market Revenue and Forecast By Modality, 2015 – 2026 ($Million)

CHAPTER 12. LATIN AMERICA Nuclear Medicine MARKET BY COUNTRY

12.1. Latin America Nuclear Medicine Market Revenue and Growth Rate, 2015 – 2026 ($Million)

12.2. Latin America Nuclear Medicine Market Revenue Share Comparison, 2015 & 2026 (%)

12.3. Brazil

12.3.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)

12.3.2. Market Revenue and Forecast By Modality, 2015 – 2026 ($Million)

12.4. Argentina

12.4.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)

12.4.2. Market Revenue and Forecast By Modality, 2015 – 2026 ($Million)

12.5. Rest of Latin America

12.5.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)

12.5.2. Market Revenue and Forecast By Modality, 2015 – 2026 ($Million)

CHAPTER 13. MIDDLE EAST Nuclear Medicine MARKET BY COUNTRY

13.1. Middle East Nuclear Medicine Market Revenue and Growth Rate, 2015 – 2026 ($Million)

13.2. Middle East Nuclear Medicine Market Revenue Share Comparison, 2015 & 2026 (%)

13.3. Saudi Arabia

13.3.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)

13.3.2. Market Revenue and Forecast By Modality, 2015 – 2026 ($Million)

13.4. UAE

13.4.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)

13.4.2. Market Revenue and Forecast By Modality, 2015 – 2026 ($Million)

13.5. Rest of Middle East

13.5.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)

13.5.2. Market Revenue and Forecast By Modality, 2015 – 2026 ($Million)

CHAPTER 14. AFRICA Nuclear Medicine MARKET BY COUNTRY

14.1. Africa Nuclear Medicine Market Revenue and Growth Rate, 2015 – 2026 ($Million)

14.2. Africa Nuclear Medicine Market Revenue Share Comparison, 2015 & 2026 (%)

14.3. South Africa

14.3.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)

14.3.2. Market Revenue and Forecast By Modality, 2015 – 2026 ($Million)

14.4. Egypt

14.4.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)

14.4.2. Market Revenue and Forecast By Modality, 2015 – 2026 ($Million)

14.5. Rest of Africa

14.5.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)

14.5.2. Market Revenue and Forecast By Modality, 2015 – 2026 ($Million)

CHAPTER 15. COMPANY PROFILE

15.1. Mallinckrodt plc.

15.1.1. Company Snapshot

15.1.2. Overview

15.1.3. Financial Overview

15.1.4. Product Portfolio

15.1.5. Key Developments

15.1.6. Strategies

15.2. General Electric Co. (healthcare division)

15.2.1. Company Snapshot

15.2.2. Overview

15.2.3. Financial Overview

15.2.4. Product Portfolio

15.2.5. Key Developments

15.2.6. Strategies

15.3. Medtronic, Inc.

15.3.1. Company Snapshot

15.3.2. Overview

15.3.3. Financial Overview

15.3.4. Product Portfolio

15.3.5. Key Developments

15.3.6. Strategies

15.4. Bayer AG

15.4.1. Company Snapshot

15.4.2. Overview

15.4.3. Financial Overview

15.4.4. Product Portfolio

15.4.5. Key Developments

15.4.6. Strategies

15.5. Cardinal Health, Inc.

15.5.1. Company Snapshot

15.5.2. Overview

15.5.3. Financial Overview

15.5.4. Product Portfolio

15.5.5. Key Developments

15.5.6. Strategies

15.6. Lantheus Medical Imaging, Inc.

15.6.1. Company Snapshot

15.6.2. Overview

15.6.3. Financial Overview

15.6.4. Product Portfolio

15.6.5. Key Developments

15.6.6. Strategies

15.7. IBA Group

15.7.1. Company Snapshot

15.7.2. Overview

15.7.3. Financial Overview

15.7.4. Product Portfolio

15.7.5. Key Developments

15.7.6. Strategies

15.8. Others

15.8.1. Company Snapshot

15.8.2. Overview

15.8.3. Financial Overview

15.8.4. Product Portfolio

15.8.5. Key Developments

15.8.6. Strategies

CHAPTER 16. RESEARCH APPROACH

16.1. Research Methodology

16.1.1. Initial Data Search

16.1.2. Secondary Research

16.1.3. Primary Research

16.2. Assumptions and Scope

Ask Query Here: frank@acumenresearchandconsulting.com or sales@acumenresearchandconsulting.com

The report is readily available and can be dispatched immediately after payment confirmation.

To Purchase this Premium Report@ ​https://www.acumenresearchandconsulting.com/buy-now/0/894

About Us:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.